Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters.
about
Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c miceHuman and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.Immunity to intestinal pathogens: lessons learned from SalmonellaCCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches.Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agendaImmunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.Leishmaniasis: current status of vaccine developmentImmunostimulatory DNA as an adjuvant in vaccination against Leishmania major.Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. TyphimuriumExpression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasisComparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Development of Vaccines against Visceral LeishmaniasisSelective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells.Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccineSalmonella enterica serovar Typhi live vector vaccines finally come of ageRecombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.Experimental models in vaccine research: malaria and leishmaniasis.Tracking the dynamics of salmonella specific T cell responses.Vaccine Development Against Leishmania donovani.Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c miceIn vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.
P2860
Q27305906-2B49AC51-FC26-4D21-876D-A765C49EEE35Q28585935-D7808778-3098-4DB3-8B6D-27F5D6EB3EEFQ33788711-8623D1C9-BC47-411E-8B40-B8D3DE4B0763Q33793565-940D8A97-5963-4294-8253-5144B5A272CEQ33855197-EECB8C9A-8C47-4FF2-B7B3-42D5EFEE1A0AQ33866797-8006B10A-8EAC-4884-BABF-83AEBF5C81DAQ33941719-D087EABF-D766-451B-811D-4B5B32CC8288Q34001298-676DC431-3A6E-4E56-8467-5608D78C8D6CQ34002047-8D20F9A0-8FEC-46C8-AC86-9778D69F2C2BQ34003274-6C181F37-2CD8-459E-B04E-1E61B9B6E4DBQ34004688-A33CAECE-E3E1-45DB-B4FA-C9C8FFEA52B6Q34009711-5BC9C982-0F9E-4C58-8BB8-45C6EB358FB6Q34521577-D6EB0971-BE10-4D43-9545-58A9AD66230CQ34529634-2A886574-2396-4C8E-9C5B-FFEAABA1D446Q35207606-62850CEC-8619-480A-9938-42C14D6436D9Q36400414-0378F146-DBC2-42C4-BE95-7D339DD5B28EQ37051032-5B2628F7-C005-4BA6-B61B-27DCC6E4F96DQ37106127-B5AA025A-4D3A-4685-9311-F08BC7F990D0Q37235277-B456AD04-775A-4F7D-9290-49B5483692AAQ37371348-C0941893-7503-4CAA-B2EC-5F00F8FE8320Q37517328-53A7F81A-D3C5-4132-9C8B-A4BF42183A80Q38012112-74A1DA30-BD08-4D03-8E46-9DDF56B8DABBQ39313487-A2356B7F-3F9A-4585-8A54-9D89AF89CF8CQ39672345-DD2E792D-5C71-4DFC-8A17-77C6C03CFC79Q45080997-7820D823-5442-4ED7-A3F2-88D1BC51CFDF
P2860
Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@ast
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@en
type
label
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@ast
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@en
prefLabel
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@ast
Vaccine efficacy of Salmonella ...... n 63 with different promoters.
@en
P2093
P2860
P1476
Vaccine efficacy of Salmonella ...... in 63 with different promoters
@en
P2093
P2860
P304
P407
P577
1997-01-01T00:00:00Z